ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

ACAD 19.21 +0.85 (4.63%)
price chart
Acadia Pharmaceuticals Enters Oversold Territory (ACAD)
In trading on Friday, shares of Acadia Pharmaceuticals Inc (NASD: ACAD) entered into oversold territory, hitting an RSI reading of 29.3, after changing hands as low as $18.50 per share.
Related articles »  
Small Cap Unusual Volume: ACADIA Pharmaceuticals (NASDAQ:ACAD ...
Thomas H. Aasen, Executive Vice President, Chief Financial Officer and Chief Business Officer of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) informed the Company that he would be retiring due to health and family-related considerations. On April 9 ...
Related articles »  
Unusual Volume: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Infosys Ltd ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) presented at the 13th Annual Needham Healthcare Conference on April 8, 2014, at 8:40 a.m.
Watch List: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Geron Corporation ...
Lakeway, NY - (MARKET NEWS CALL) - 4/15/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
ACADIA Pharmaceuticals Inc. (ACAD) Soars on Unusual Volume with, NPS ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical firm aimed towards on the development and commercialization of innovative medicines that address unmet medical requirements in neurological and associated central nervous system ...
Investors Alert: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Keryx ...  Market News Call
Biotech Bullish Stocks: EXACT Sciences Corporation (NASDAQ:EXAS ...  Gaining Green
Related articles »  
ACADIA Pharmaceuticals to Present at the 13th Annual Needham Healthcare ...
SAN DIEGO, Apr 01, 2014 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological ...
Biotech Losers: ACADIA Pharmaceuticals (NASDAQ:ACAD), Incyte Corporation ...
Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014.
Related articles »  
Biotechnology Bears In Concerns- Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) [Trend Analysis] after opening at $17.87 hit its intraday high price of $18.36 moreover then finished at $18.36 by shares raised 3.03%.
Related articles »  
News Recap - Celldex Therapeutics, Inc. (CLDX), Keryx Biopharmaceuticals ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)'s reported the decrease of -4.99% to close at $19.04 with the overall traded volume of 2.67 million shares.
NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA ...
Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014.
Related articles »